Form 4: Akamai CTO Sells 3,500 Shares Under 10b5-1 Plan

Akamai Technologies' Chief Technology Officer, Robert Blumofe, sold 3,500 shares of common stock for $108 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Robert Blumofe, Chief Technology Officer of Akamai Technologies Inc. (AKAM), reported a sale of company common stock.
• The transaction involved the disposition of 3,500 shares of common stock.
• The shares were sold at a price of $108 per share.
• The sale was executed on February 13, 2026.
• This transaction was conducted pursuant to a Rule 10b5-1 trading plan adopted by Dr. Blumofe on March 12, 2025.
• Following the transaction, Dr. Blumofe directly beneficially owns 14,574 shares of common stock.
• Additionally, 103.347 shares are indirectly owned via a 401(k) Plan as of February 12, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale reduces direct ownership, its execution under a pre-planned 10b5-1 plan mitigates concerns about negative sentiment regarding the company's future.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 plan, indicating a planned transaction rather than an immediate reaction to new information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by investors as it reduces the insider's direct equity stake in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Akamai Technologies' future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider sales under Rule 10b5-1 plans are common practice for executives to manage personal finances while complying with insider trading regulations. Such pre-scheduled sales are generally viewed as less indicative of management's sentiment about the company's immediate prospects compared to unscheduled, open-market sales.

Comparison to Industry Standards

• This Form 4 filing is a standard disclosure for insider transactions and does not provide information that allows for a direct comparison to industry-specific operational or financial benchmarks. The transaction itself is a routine insider sale under a pre-arranged plan, a common practice across all publicly traded companies.

Stakeholder Impact

• Shareholders: The sale by a key executive could be interpreted in various ways, but the 10b5-1 plan suggests it's for personal financial planning rather than a reflection of company performance. The impact is likely minimal given the pre-planned nature.

Key Dates

Recommendation

The insider sale by the CTO, while reducing his direct stake, was conducted under a pre-arranged 10b5-1 plan. This type of transaction is generally considered routine for executive compensation and personal financial management and does not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing.

Keywords

Akamai Technologies, AKAM, Robert Blumofe, CTO, Insider Sale, Form 4, 10b5-1 Plan, Stock Transaction, Equity Disclosure